Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

January 2005

Hey! We Are Halfway Through the 2000ā€™s

Commentary and Opinion by R. Lewis Dark /

WITHOUT SPLITTING HAIRS ABOUT WHETHER THE NEW MILLENNIUM started on January 1, 2000 or January 1, 2001 (although official millennium celebrations heavily favored the former date), I would like to call your attention to an important fact: 2005 is the half-way point in the current decade. Look what has changed since 2000. No longer do […]

To access this post, you must purchase The Dark Report.

Hey! We Are Halfway Through the 2000ā€™s Read More Ā»

Bi-Annual Look at Trends Reshaping Clinical Labs

The Dark Report /

CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number of reference and esoteric tests, the number

To access this post, you must purchase The Dark Report.

Bi-Annual Look at Trends Reshaping Clinical Labs Read More Ā»

“January 24, 2005 Intelligence: Late Breaking Lab News”

Late Breaking Lab News /

Blood-alcohol testing in the emergency room can generate surprising results. That was certainly the case in Plovdiv, Bulgaria on December 20, 2004. A 67-year old pedestrian, hit by a car, was taken to the emergency room. Using a breath analyzer, his blood-alcohol level registered at .914! Physicians and police were amazed, since the patient was

To access this post, you must purchase The Dark Report.

“January 24, 2005 Intelligence: Late Breaking Lab News” Read More Ā»

Government Health Contracting Has a Seamy Side

Commentary and Opinion by R. Lewis Dark /

WHAT MIGHT HAPPEN TO YOUR LABORATORY if either or both Medicare and your stateā€™s Medicaid program initiated some type of competitive bidding for laboratory testing services? Iā€™ll bet there would be a level of financial pain, not to mention the consequences to physicians and patients as long-standing laboratory relationships were changed in favor of the

To access this post, you must purchase The Dark Report.

Government Health Contracting Has a Seamy Side Read More Ā»

OIG Releases Opinion On AP Lab Condominiums

Anatomic Pathology /

CEO SUMMARY: In responding to a request for an advisory opinion, the Office of the Inspector General (OIG) issued an advisory opinion which declares that anatomic pathology (AP) lab condominiums ā€œcould potentially generate prohibited remuneration under the anti-kickback statute.ā€ It also voices concerns about how the operation of such AP laboratory condos could violate the

To access this post, you must purchase The Dark Report.

OIG Releases Opinion On AP Lab Condominiums Read More Ā»

Analysis of OIGā€™s Opinion Shows Compliance Shift

Anatomic Pathology /

CEO SUMMARY: Attorney Richard Cooper believes the latest Advisory Opinion by the Office of the Inspector General (OIG) is consistent with its earlier anti-kickback law pronouncements about situations where a physician is in a position to profit from the patients he/she refers. Cooper also comments on the vulnerability of the anatomic pathology laboratory condominium to

To access this post, you must purchase The Dark Report.

Analysis of OIGā€™s Opinion Shows Compliance Shift Read More Ā»

More Lab Consolidation: LabCorp Buys US LABS

Clinical Laboratory Trends /

CEO SUMMARY: Following three years of rapid growth in specimen volume and revenues, US LABS has accepted a purchase offer from Laboratory Corporation of America. Both US LABSā€™ fast growth and its sale to a national lab demonstrate that there is still opportunity in laboratory testingā€”and that one of the two blood brothers is ever

To access this post, you must purchase The Dark Report.

More Lab Consolidation: LabCorp Buys US LABS Read More Ā»

Roche/Affymetrix Microarray Cleared for Clinical Use by FDA

Molecular Diagnostics /

MOLECULAR DIAGNOSTICS took a big step forward in December. During the month, the Food and Drug Administration (FDA) cleared the first microarray instrument system and microarray-based laboratory test for clinical use. The FDA announced on December 23, 2004 that it had cleared the Gene-ChipĀ® System (GCS) 3000Dx for clinical use. Affymetrix, Inc. of Santa Clara,

To access this post, you must purchase The Dark Report.

Roche/Affymetrix Microarray Cleared for Clinical Use by FDA Read More Ā»

Florida Medicaid Contract Is On-Again, Off-Again

Managed Care Contracts /

CEO SUMMARY: Start with a flawed idea: Medicaid lab testing costs in Florida can be cut by awarding an exclusive statewide contract to one laboratory company. Compound that bad idea by designing a contract awards process that guarantees the state will pay twice for a number of tests while at the same time reducing patient

To access this post, you must purchase The Dark Report.

Florida Medicaid Contract Is On-Again, Off-Again Read More Ā»

“January 3, 2005 Intelligence: Late Breaking Lab News”

Late Breaking Lab News /

More evidence of the move to an all computer economy has surfaced. During 2003, consumer use of credit cards, debit cards, and other electronic payment methods eclipsed paper checks for the first time. The study was done by the Federal Reserve Bank of Atlanta. It reports that 36.7 billion checks were paid in 2003, for

To access this post, you must purchase The Dark Report.

“January 3, 2005 Intelligence: Late Breaking Lab News” Read More Ā»

Facebook-f Twitter Linkedin-in

The Dark Report ā€¢ 21806 Briarcliff Dr ā€¢ Spicewood, TX 78669
Phone: 512-264-7103
Email: info@darkreport.com

Ā© 2025 The Dark Report. All rights reserved.

;